Allogeneic bone marrow derived mesenchymal stem cells (Indiana University)

N/A

Report date: 2023/01/12 15:29:58

Base Information

Drug NameAllogeneic bone marrow derived mesenchymal stem cells (Indiana University)
Drug Alias NamecBMA异体骨髓间充质干细胞-Indiana UniversityMSCs (Indiana University)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAmputation, TraumaticIschemiaPathologic Processes +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesIndiana University
Inactive CompaniesN/A
Active IndicationsAmputation, TraumaticIschemiaPathologic Processes +[9] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A